Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Rheumatology
•
General Rheumatology
•
Infectious Disease
•
Tuberculosis
•
DMARD
•
Primary Care
When is it safe to resume DMARDs in a patient who was diagnosed with active TB and started on treatment?
Related Questions
Can inflammatory arthritis develop in patients with a history of chronic hepatitis B?
How do you handle medication refills for patients on traditional DMARDs who are lost to follow-up?
How do you approach an asymptomatic patient with evidence of intense radiotracer activity at the left sternoclavicular joint on bone scan with a history of SAPHO syndrome on Humira?
Do you continue PJP prophylaxis indefinitely in patients on rituximab maintenance therapy?
Do you have to extend treatment for acute Lyme disease if a patient is on high dose steroids for another indication?
Are SGLT2 inhibitors contraindicated in patients with osteoporosis and history of vertebral and hip fractures?
In a patient with negative Hep B surface Ag, Hep B surface antibody+, and Hep B core antibody+ serologies, do you initiate antiviral prophylaxis (e.g. entecavir) prior to starting rituximab?
Do you regularly recommend an immunological workup for patients with suspected immunodeficiency or defer to immunology?
How do you treat nocturnal leg cramps?
What are your vaccine recommendations while patients are on biologics?
